The widespread use of cell and gene therapy manufacturing gets restricted by three main factors which include high production costs and regulatory complexities along with limited scalability. Modern automations systems as well as AI and bioprocessing technology enhance capability and reduce expense. The successful resolution of these difficulties will open life-saving medications to w... https://www.pharmafocusamerica.com/articles/challenges-opportunities-cell-gene-therapy-manufacturing